Question $2$ Arantxa Corporation made the following purchases of investments during $2014,$ the first year in which Arantxa invested in equity securities: $1.$ On January $15,$ purchased $8,370$ shares of Nirmala Corp.$$s common shares at $$31\mathrm{.}16$ per share plus commission of $$1,841.2.$ On April $1,$ purchased $4,650$ shares of Oxana Corp.$$s common shares at $$48$ per share plus commission of $$3,134.3.$ On September $10,$ purchased $6,510$ shares of WTA Corp.$$s preferred shares at $$24\mathrm{.}65$ per share plus commission of $$2,706.$ On May $20,2014,$ Arantxa sold $2,790$ of the Nirmala common shares at a market price of $$33$ per share less brokerage commissions of $$2,651.$ The year$-$end fair values per share were as follows: Nirmala $$28$; Oxana $$51$; and WTA $$26.$ The chief accountant of Arantxa tells you that Arantxa Corporation holds these investments with the intention of selling them in order to earn short$-$term profits from appreciation in their prices and accounts for them using the fair value though net income model, with no separate reporting of dividends and other types of FV$-$NI investment income and losses. Assume that Arantxa Corporation follows IFRS, and specifically IAS $39.$ Collapse question part $($a$)$ Prepare the journal entries to record the three investments. $($Credit account titles are automatically indented when the amount is entered. Do not indent manually. Round answers to $0$ decimal places, e$.$g$.5,275.)$